Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study-Reference-Cited by-同舟云学术

Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study

Published:2024-01-11 Issue:3 Volume:137 Page:353-355
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Wang Xuechen¹,Li Fangyuan¹,Wang Chengshuo²³,Huang Kai¹,Shen Shen²³,Wang Ming²³,Jin Jianmin¹³,Zhang Luo²³⁴⁵

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

2. Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

3. Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China

4. Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

5. Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Chronic Rhinosinusitis with Nasal Polyps and Asthma;J Allergy Clin Immunol Pract,2021

2. Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps;Clin Exp Allergy,2020

3. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: Findings from a national cross-sectional study;Lancet Respir Med,2020

4. Risk factors associated with comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study;BMC Pulm Med,2022

5. Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: A cross-sectional study;Respir Res,2022